Verschiedene (Pharma-API) · Undisclosed · Wachstums-/Buyout-Finanzierungen

Private equity firms are eyeing growth opportunities in the active pharmaceutical ingredient (API) space. Five deals are highlighted where PE firms like Astorg, EQT, New Mountain Capital, and TA Associates are buying and selling API assets.